A new target for alcoholism treatment: Kappa opioid receptors

Reports new study in Biological Psychiatry

2014-05-22

(Press-News.org) Philadelphia, PA, May 22, 2014 – The list of brain receptor targets for opiates reads like a fraternity: Mu Delta Kappa. The mu opioid receptor is the primary target for morphine and endogenous opioids like endorphin, whereas the delta opioid receptor shows the highest affinity for endogenous enkephalins. The kappa opioid receptor (KOR) is very interesting, but the least understood of the opiate receptor family.

Until now, the mu opioid receptor received the most attention in alcoholism research. Naltrexone, a drug approved by the U.S. Food and Drug Administration for the treatment of alcoholism, acts by blocking opiate action at brain receptors and is most potent at the mu opioid receptor. In addition, research has suggested that a variant of the gene that codes for the mu opioid receptor (OPRM1) may be associated with the risk for alcoholism and the response to naltrexone treatment.

However, naltrexone also acts at the kappa opioid receptor and it has not been clear whether this effect of naltrexone is relevant to alcoholism treatment.

A growing body of research in animals implicates the KOR in alcoholism. Stimulation of the KOR, which occurs with alcohol intake, is thought to produce unpleasant and aversive effects. This receptor is hypothesized to play a role in alcohol dependence, at least in part, by promoting negative reinforcement processes. In other words, the theory postulates that during development of alcohol dependence, the KOR system becomes overstimulated, producing dysphoria and anhedonia, which then leads to further alcohol seeking and escalation of alcohol intake that serves to self-medicate those negative symptoms.

A new study in Biological Psychiatry, led by Dr. Brendan Walker at Washington State University, used a rat model of alcohol dependence to directly investigate the KOR system following chronic alcohol exposure and withdrawal.

They found that the KOR system is dysregulated in the amygdala of alcohol-dependent rats, a vital brain region with many functions, including regulation of emotional behavior and decision-making. Chronic alcohol consumption is known to cause neuroadaptations in the amygdala. In this study specifically, they found increased dynorphin A and increased KOR signaling in the amygdala of alcohol-dependent rats.

When the rats were in acute alcohol withdrawal, the researchers administered different drugs, each of which target the KOR system in precise ways, directly into the amygdala. Using this site-specific antagonism, they observed that alcohol dependence-related KOR dysregulation directly contributes to the excessive alcohol consumption that occurs during withdrawal.

"These data provide important new support for the hypothesis that kappa opioid receptor blockers might play a role in the treatment of alcoholism," said Dr. John Krystal, Editor of Biological Psychiatry. "This study suggests that one role might be to prevent a relapse to alcohol use among patients recently withdrawn from alcohol."

"This dataset demonstrates the extensive nature of the neuroadaptations the brain undergoes when chronically exposed to alcohol. The implications of these results are far reaching and should help guide pharmacotherapeutic development efforts for the treatment of alcohol use disorders," said Walker. "Pharmacological compounds that alleviate the negative emotional / mood states that accompany alcohol withdrawal, by attenuating the excessive signaling in the dynorphin / kappa-opioid receptor system, should result in enhanced treatment compliance and facilitate the transition away from alcohol dependence."

Additional extensive research will be necessary to identify and test the effectiveness of specific drugs that act on the KOR system, but these findings provide researchers with a potentially successful path forward to developing new drugs for the treatment of alcoholism.

INFORMATION: The article is "The One-Two Punch of Alcoholism: Role of Central Amygdala Dynorphins/Kappa-Opioid Receptors" by Jessica L. Kissler, Sunil Sirohi, Daniel J. Reis, Heiko T. Jansen, Raymond M. Quock, Daniel G. Smith, and Brendan M. Walker (doi: 10.1016/j.biopsych.2013.03.014). The article appears in Biological Psychiatry, Volume 75, Issue 10 (May 15, 2014), published by Elsevier.

Notes for editors Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Brendan M. Walker at +1 509 335 8526 or brendan.walker@wsu.edu.

The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine, Chief of Psychiatry at Yale-New Haven Hospital, and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.

About Biological Psychiatry Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 4th out of 135 Psychiatry titles and 13th out of 251 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2012 Impact Factor score for Biological Psychiatry is 9.247.

About Elsevier Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Rhiannon Bugno,
Editorial Office
+1 214 648 0880
Biol.Psych@utsouthwestern.edu

ELSE PRESS RELEASES FROM THIS DATE:

Higher discharge rate for BPD in children and adolescents in the US compared to UK

2014-05-22

Washington D.C., May 22, 2014 – A study published in the June 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found a very much higher discharge rate for pediatric bipolar (PBD) in children and adolescents aged 1-19 years in the US compared to England between the years 2000-2010. Using the English NHS Hospital Episode Statistics (HES) dataset and the US National Hospital Discharge Survey (NHDS) to compare US and English discharge rates for PBD over the period 2000-2010, the authors found a 72.1-fold higher discharge rate for pediatric ...

Liquid crystal as lubricant

2014-05-22

Lubricants are used in motors, axels, ventilators and manufacturing machines. Although lubricants are widely used, there have been almost no fundamental innovations for this product in the last twenty years. Together with a consortium, the Fraunhofer Institute for Mechanics of Materials IWM in Freiburg has developed an entirely new class of substance that could change everything: liquid crystalline lubricant. Its chemical makeup sets it apart; although it is a liquid, the molecules display directional properties like crystals do. When two surfaces move in opposite directions, ...

Fossil avatars are transforming palaeontology

2014-05-22

Palaeontology has traditionally proceeded slowly, with individual scientists labouring for years or even decades over the interpretation of single fossils which they have gradually recovered from entombing rock, sand grain by sand grain, using all manner of dental drills and needles. The introduction of X-ray tomography has revolutionized the way that fossils are studied, allowing them to be virtually extracted from the rock in a fraction of the time necessary to prepare specimens by hand and without the risk of damaging the fossil. The resulting fossil avatars not ...

Drug-target database lets researchers match old drugs to new uses

2014-05-22

There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities. Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for which they were originally approved. Repurposing these drugs depends on matching drugs to targets. A study recently published in the journal Bioinformatics describes a new database and pattern-matching algorithm that allows researchers to evaluate rational drugs and drug combinations, and also recommends a new drug combination to treat drug-resistant non-small ...

TSRI scientists catch misguided DNA-repair proteins in the act

2014-05-22

LA JOLLA, CA – May 22, 2014 – Accumulation of DNA damage can cause aggressive forms of cancer and accelerated aging, so the body's DNA repair mechanisms are normally key to good health. However, in some diseases the DNA repair machinery can become harmful. Scientists led by a group of researchers at The Scripps Research Institute (TSRI) in La Jolla, CA, have discovered some of the key proteins involved in one type of DNA repair gone awry. The focus of the new study, published in the May 22, 2014 edition of the journal Cell Reports, is a protein called Ring1b. The TSRI ...

Univ. of MD researchers identify fat-storage gene mutation that may increase diabetes risk

2014-05-22

BALTIMORE – May 21, 2014. Researchers at the University of Maryland School of Medicine have identified a mutation in a fat-storage gene that appears to increase the risk for type 2 diabetes and other metabolic disorders, according to a study published online today in the New England Journal of Medicine. The researchers discovered the mutation in the hormone-sensitive lipase (HSL) gene by studying the DNA of more than 2,700 people in the Old Order Amish community in Lancaster County, Pa. HSL is a key enzyme involved in breaking down stored fat (triglycerides) into fatty ...

Ka'ena Volcano: First building block for O'ahu discovered

2014-05-22

Boulder, Colo., USA – Researcher John Sinton of the University of Hawai'i along with colleagues from the Monterrey Bay Aquarium and the French National Center for Scientific Research have announced the discovery of an ancient Hawaiian volcano. Now located in a region of shallow bathymetry extending about 100 km WNW from Ka'ena Point at the western tip of O'ahu, this volcano, which they have named Ka'ena, would have risen about 1,000 meters above sea level 3.5 million years ago. Sinton and colleagues have found compelling evidence beneath the sea that this long-lived ...

Intuitions about the causes of rising obesity are often wrong, researchers report

2014-05-22

CHAMPAIGN, Ill. — Everything you think you know about the causes of rising obesity in the U.S. might be wrong, researchers say in a new report. Contrary to popular belief, people are exercising more today, have more leisure time and better access to fresh, affordable food – including fruits and vegetables – than they did in past decades. And while troubling disparities exist among various groups, most economic, educational, and racial or ethnic groups have seen their obesity levels rise at similar rates since the mid-1980s, the researchers report. The new analysis appears ...

Review says inexpensive food a key factor in rising obesity

2014-05-22

ATLANTA May 22, 2014—A new review summarizes what is known about economic factors tied to the obesity epidemic in the United States and concludes many common beliefs are wrong. The review, authored by Roland Sturm, PhD of RAND Corporation and Ruopeng An, PhD, of the University of Illinois at Urbana-Champaign, notes that paradoxically, rising obesity rates coincided with increases in leisure time, increased fruit and vegetable availability, and increased exercise uptake. The review appears early online in CA: A Cancer Journal for Clinicians and finds at least one factor ...

Scientists find new way to combat drug resistance in skin cancer

2014-05-22

RAPID RESISTANCE to vemurafenib – a treatment for a type of advanced melanoma, the deadliest form of skin cancer – could be prevented by blocking a druggable family of proteins, according to research* published in Nature Communications today (Thursday). Scientists at the Cancer Research UK Manchester Institute, based at the University of Manchester, have revealed the MLK family of four enzymes 'undoes' the tumour-shrinking effects of vemurafenib**. Around half of metastatic melanomas – aggressive skin cancer that has spread to other parts of the body – are caused by ...

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

New study finds air pollution increases inflammation primarily in patients with heart disease

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski

A new target for alcoholism treatment: Kappa opioid receptors

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: